-
What scientists know so far about Nepal's deadly floods
-
How we might hear new Dolly Parton music in the future
-
US general visits Colombia to discuss war on drugs
-
Nvidia doubles revenue, forecasts even more AI spending
-
Meta settlement puts social media industry on notice: 'There will be more'
-
Canada renews push to boycott US products
-
NFL owners approve record Seahawks sale
-
Savio scores on debut as Spurs set-up League Cup tie with Liverpool
-
Nigerian armed groups net nearly $6 mn in ransoms: study
-
Brazil sues Discord over child safety measures, demands $100 mln in damages
-
Savio scores on debut as Spurs advance in League Cup
-
Alberta NDP Urges Smith to Postpone Separation Vote Amid Trade War
-
Mbappe hits treble as Real Madrid thrash Real Sociedad
-
Fenerbahce stun Lyon in Champions League as AEK crush Levski
-
At Dollywood, superfans honor the late singer and local hero
-
Why Global Finance Still Relies on Wall Street Despite Diversification Trends
-
Stocks mixed as oil drops, US inflation stays high
-
Bethlehem Father Seeks Aid for Special Needs Children Amid Health Crisis
-
Bolivia's Paz appoints new economy minister amid bailout talks
-
LIV Golf to lay off majority of staff
-
US designates UK-based Palestine Action as foreign 'terrorist group'
-
How narwhal 'scientists' track Arctic warming
-
'Rocky Horror Picture Show' star Tim Curry dead at 80
-
Iran says US sanctions will achieve nothing
-
American Moll wins women's pole vault at Zurich city event
-
Essential Dolly: five key Parton songs
-
As Canada takes on US tariffs, what's behind the David and Goliath fight?
-
Veteran promoter Warren says it's Joshua's job to agree Fury fight
-
UEFA 'likely' to drop threat to boycott FIFA tournaments: source
-
Ex-champ Wawrinka gets last-minute wildcard to US Open
-
US disrupts platforms allegedly used by Chinese hackers
-
Brennan blasts to Vuelta stage five victory, Pogacar holds lead
-
The foreign tourists missing in Nepal's flash floods
-
What could change for US teens on Instagram and Facebook
-
Hundreds missing after Nepal-Tibet flood kills 98
-
Meta, US states agree $16.7 bn settlement in landmark teen safety case
-
CIA director was on 'semi-routine' mission in Moscow: Trump
-
'Point of no return' if Israel-Hamas truce fails: US envoy to Gaza board
-
Aldeguer switches to Rossi's VR46 for next season
-
Barcelona holding out hope for Alvarez as Atletico resist sale
-
Rent TRON Energy and Reduce USDT Fees : TronBid Expands Marketplace
-
Werro basks in new status, shelves world record talk
-
Pakistan captain Babar Azam returns against England '90 percent fit'
-
Bill Gates warns world unprepared for AI upheaval
-
Stocks mixed as oil drops, inflation stays high
-
Prince Harry and family arrive back in Britain: UK media
-
Improving standards transform pole vault as spectacle, says Duplantis
-
German plan for sugar tax on Coke Zero fizzles out
-
India close in on win despite Sri Lanka fightback in second Test
-
Deadly flood hits Nepal-Tibet border, hundreds unaccounted for
Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories
Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories
SINGAPORE, SG / ACCESS Newswire / March 7, 2026 / Dipylon Medical, a specialized provider of laboratory and diagnostic technologies, today announced the expansion of its portfolio of clinical microbiology and molecular diagnostic equipment, supporting laboratories, hospitals, and research institutions with advanced tools for infectious disease detection and biomedical research.

The expansion reflects growing global demand for molecular diagnostics, microbiology testing, and automated laboratory workflows, as healthcare systems increasingly rely on precision testing to detect pathogens, monitor outbreaks, and guide treatment decisions.
Clinical microbiology technologies-including PCR thermocyclers, DNA and RNA purification systems, and hematology analyzers-play a central role in modern laboratory diagnostics, enabling faster and more accurate identification of microorganisms and antimicrobial resistance.
"Laboratory diagnostics is entering a new era driven by automation, molecular biology, and high-throughput testing," said CEO, Kimberly Steckler "Our mission is to help laboratories access reliable, high-performance equipment that supports accurate diagnostics and improved patient care."
Growing Importance of Clinical Microbiology Technologies
Recent developments in the diagnostics industry highlight the strategic importance of microbiology testing and molecular diagnostics. In one notable example, Beckman Coulter announced an agreement to acquire the clinical microbiology business of Siemens Healthcare Diagnostics, including its MicroScan systems used for microbial identification and antibiotic susceptibility testing.
These systems help laboratories identify microorganisms and determine antibiotic sensitivity, providing clinicians with critical information for managing infectious diseases and combating antimicrobial resistance.
Industry consolidation and investment in microbiology technologies reflect the expanding role of laboratory diagnostics in modern healthcare.
Advanced Diagnostic Equipment for Modern Laboratories
Dipylon Medical supplies a wide range of laboratory technologies designed for clinical microbiology, molecular biology, and diagnostic research, including:
PCR Thermocyclers for DNA amplification and pathogen detection
DNA & RNA Purification Systems for molecular research and sequencing preparation
Supporting modern laboratories with clinical chemistry analyzers.
Expanding access to PCR thermocycler for modern diagnostic laboratories.
These systems are used across hospitals, diagnostic laboratories, biotechnology research facilities, and pharmaceutical companies.
Supporting the Future of Molecular Diagnostics
Advances in molecular diagnostics are transforming the way laboratories detect and monitor infectious diseases. Technologies such as PCR testing and automated nucleic acid purification have become essential tools in identifying viral, bacterial, and genetic conditions.
As global healthcare systems continue to prioritize early detection and precision medicine, laboratories are investing in equipment that can deliver fast turnaround times, high accuracy, and scalable testing capacity.
Dipylon Medical aims to support this transformation by providing access to trusted diagnostic technologies and laboratory equipment from leading manufacturers.
"Reliable laboratory equipment is the foundation of accurate diagnostics," the company added. "By supplying advanced microbiology and molecular biology systems, we help laboratories deliver faster results and better outcomes for patients."
About Dipylon Medical
Dipylon Medical is a supplier of clinical microbiology and laboratory diagnostic equipment, serving hospitals, research laboratories, and healthcare institutions worldwide. The company specializes in technologies for molecular biology, microbiology testing, and automated laboratory workflows, including PCR thermocyclers, DNA and RNA purification systems, and hematology analyzers.
Through its global network and industry expertise, Dipylon Medical supports laboratories with reliable diagnostic solutions that enhance research, clinical testing, and patient care.
Learn more:
https://dipylonmedical.com/about/
Media Contact
Kim Lee
Public Relation Manager
Dipylon Medical
+1812-768-6999
Email: [email protected]
Website: https://dipylonmedical.com/
SOURCE: Dipylon Medical
View the original press release on ACCESS Newswire
A.Clark--AT